The Effect of Dihydralazine on Kidney Function and Hormones in Healthy Individuals
NCT00311974 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2010-02-18
Summary
We, the investigators at Holstebro Hospital, want to test the hypothesis that dihydralazine leads to the activation of the sympathetic nervous system in healthy individuals.
Conditions
- Healthy
Interventions
- DRUG
-
Dihydralazine
Sponsors & Collaborators
-
Regional Hospital Holstebro
lead OTHER
Principal Investigators
-
Erling B Pedersen, Professor · Department of Medical Research, Holstebro Hospital, Denmark
-
Henrik Vase, MD · Department of Medical Research, Holstebro Hospital, Denmark
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-04-30
- Primary Completion
- 2007-11-30
- Completion
- 2007-11-30
Countries
- Denmark
Study Locations
More Related Trials
-
Cardiovascular Effects of Adderall in Healthy Adults.
NCT02979327 ·Status: COMPLETED ·Phase: PHASE4
-
The Study of Pharmacokinetics and Pharmacodynamics of Huperzine a Injection in Healthy Chinese Subjects
NCT06570655 ·Status: COMPLETED ·Phase: PHASE1
-
Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism
NCT02127840 ·Status: UNKNOWN ·Phase: PHASE4
-
Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment and in Healthy Subjects
NCT01934166 ·Status: COMPLETED ·Phase: PHASE1
-
Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?
NCT00430170 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Dietary Nitrate on Age-related Vascular Function
NCT01729234 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Salmeterol Effect on Exercise Performance
NCT06655012 ·Status: RECRUITING ·Phase: NA
-
The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil
NCT01131845 ·Status: COMPLETED ·Phase: PHASE1
-
Beta2-adrenergic Agonism and Muscle Remodelling
NCT03565302 ·Status: UNKNOWN ·Phase: NA
-
Food-effect Study on Uracil and Dihydrouracil Levels as a Diagnostic Marker of Dihydropyrimidine Dehydrogenase Activity
NCT02718664 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of the Basel Phenotyping Cocktail Combination Capsule
NCT03247699 ·Status: COMPLETED ·Phase: NA
-
Multiple Dose, Double-Blind, Placebo and Active Controlled Study of Pharmacokinetics of Diractin® as Well as Safety and Efficacy for the Treatment of Muscle Soreness
NCT00745771 ·Status: COMPLETED ·Phase: PHASE2
-
Autonomic Nervous System and Chronic Fatigue Syndrome
NCT00580619 ·Status: COMPLETED ·Phase: PHASE1
-
The Influence of Exercise and Hydration to the Pharmacological Response to Inhaled Terbutalin and Salbutamol in Men
NCT05749523 ·Status: WITHDRAWN ·Phase: PHASE4
-
Regulation of KATP Channels and Na+/K+ ATPase in Relation to Fatigue Development
NCT03775902 ·Status: COMPLETED ·Phase: NA
-
Determination of Drugs and Their Metabolites in Hospitalized Patients
NCT01702545 ·Status: UNKNOWN
-
Generation of Biological Samples Positive to Hydrochlorothiazide for Anti-doping Control
NCT04197622 ·Status: COMPLETED ·Phase: PHASE1
-
Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome
NCT00977171 ·Status: TERMINATED ·Phase: PHASE2
-
Physiological Response to Salbutamol and Exercise
NCT03902106 ·Status: UNKNOWN ·Phase: NA
-
Effect of Polymorphisms in the Adenosine a2a Receptor Gene and AMPD2 Gene on Adenosine-Induced Vasodilation and Reactive Hyperemia
NCT00253929 ·Status: COMPLETED ·Phase: NA
-
Effects of Phenylephrine on Cardiac Preload
NCT02739399 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of Methylphenidate on Performance in the Cold
NCT04283877 ·Status: UNKNOWN ·Phase: PHASE4
-
Helping Olfaction and Nutrition On Renal Replacement
NCT02479451 ·Status: COMPLETED ·Phase: PHASE2
-
The Norwegian Study of Chronic Fatigue Syndrome in Adolescents: Pathophysiology and Intervention Trial
NCT01040429 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Nasal Deposition and Clearance of Ketorolac Solution Administered Using the Valois Nasal Spray Device
NCT01356212 ·Status: COMPLETED ·Phase: PHASE1